BioCorRx Inc
OTC:BICX

Watchlist Manager
BioCorRx Inc Logo
BioCorRx Inc
OTC:BICX
Watchlist
Price: 0.3005 USD -20.92% Market Closed
Market Cap: $7.1m

Net Margin

-1 509.7%
Current
Improving
by 9 547.2%
vs 3-y average of -11 056.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-1 509.7%
=
Net Income
$-4.7m
/
Revenue
$313.1k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-1 509.7%
=
Net Income
$-4.7m
/
Revenue
$313.1k

Market Distribution

Lower than 95% of companies in the United States of America
Percentile
5th
Based on 15 072 companies
5th percentile
-1 509.7%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

BioCorRx Inc
Glance View

Market Cap
7.1m USD
Industry
Health Care

BioCorRx, Inc. engages in the provision of alcoholism and opioid addiction treatment. The company is headquartered in Anaheim, California. The company went IPO on 2010-08-31. The firm's BioCorRx Recovery Program is a non-addictive, medication-assisted treatment (MAT) program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. The company is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. Its products include BICX101 and BICX104. Its lead candidate, BICX101, is a sustained release, injectable naltrexone for the treatment of opioid abuse and alcoholism. The company is also developing an implantable naltrexone treatment, BICX104, a long-acting naltrexone implant that can last several months for the treatment of opioid dependence and alcohol use disorders. Its subsidiary is BioCorRx Pharmaceuticals, Inc.

BICX Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-1 509.7%
=
Net Income
$-4.7m
/
Revenue
$313.1k
What is BioCorRx Inc's current Net Margin?

The current Net Margin for BioCorRx Inc is -1 509.7%, which is above its 3-year median of -11 056.9%.

How has Net Margin changed over time?

Over the last 3 years, BioCorRx Inc’s Net Margin has increased from -8 150% to -1 509.7%. During this period, it reached a low of -66 313% on Dec 31, 2024 and a high of -1 509.7% on Jul 30, 2025.

Back to Top